article thumbnail

STAT+: Chick-fil-A drops a ‘No Antibiotic Ever’ pledge on chicken over supply issues

STAT

Notably, Tyson Foods, which is one of the biggest poultry suppliers, a few months ago removed the “No Antibiotics Ever” label from its chickens after reportedly encountering higher costs. Continue to STAT+ to read the full story…

Labelling 138
article thumbnail

STAT+: A Q&A with Vertex founder Joshua Boger on Casgevy, the biotech industry, and Elon Musk

STAT

Boger, 72, founded Vertex in 1989 and served in various roles until 2017. The clear column in his kitchen filled with racks of wine still holds a Vertex-labeled wine bottle.) He was involved in many of the turning points that led to Friday’s landmark approval, but he still finds it hard to believe.

Labelling 135
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Look out, Teva. Neurocrine's Ingrezza wins Huntington's disease FDA nod to rival Austedo

Fierce Pharma

Ingrezza was first approved in tardive dyskinesia in 2017. With its second approval, the medication’s label now largely stacks up to Teva Pharmaceuticals’ Austedo. . | The FDA approved Ingrezza capsules to treat adult with chorea associated with Huntington’s disease.

FDA 98
article thumbnail

FDA Finalizes Guidance Re Enforcement Policy for Homeopathic Drugs

The FDA Law Blog

In 2017, it decided to withdraw the compliance policy guide (CPG; from 1988) under which, for decades, the Agency essentially had permitted the marketing of over-the-counter homeopathic drug products. It issued a draft guidance in 2017 which was subsequently revised in 2019.

FDA 98
article thumbnail

Traditional Meat Industry’s Beef With Alternative Protein Continues with the FAIR on Labels Act

The FDA Law Blog

Many individual states have pursued some type of legislation to restrict the use of traditional meat terminology for the labeling of APPs. Many states have proposed but failed to enact legislation regulating the labeling of APPs, in some cases due to concerns of potential legal challenges based on federal preemption claims.

article thumbnail

Teva asks SCOTUS to overturn “skinny label” verdict on GSK drug

pharmaphorum

The case hinges around the concept of “ skinny labelling ” which was introduced to stop drugmakers extending the exclusivity period for their branded medicines – through a stream of new indications or patient populations – that can be protected with so-called “use” patents. The substance patent expired in 2007.

article thumbnail

STAT+: Drug wholesaler owner indicted for alleged role in diverting Gilead and J&J HIV medicines

STAT

He allegedly worked with several other individuals and pharmacies between 2017 and 2021 as part of the scheme. Reconfiguring bottles and labels for distributing medicines is known as misbranding or diverting legitimate prescription drugs. Steven Diamantstein, who runs Scripts Wholesale in Brooklyn, N.Y.,